BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37065746)

  • 1. ncRNA-mediated upregulation of
    Zou W; Wang H; Wu D; Wu Y; Zhou K; Lian Y; Chang G; Feng Y; Liang J; Huang G
    Front Endocrinol (Lausanne); 2023; 14():1093042. PubMed ID: 37065746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the
    Zhou C; Liang Y; Zhou L; Yan Y; Liu N; Zhang R; Huang Y; Wang M; Tang Y; Ali DW; Wang Y; Michalak M; Chen XZ; Tang J
    Autophagy; 2021 Oct; 17(10):3175-3195. PubMed ID: 32972302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma.
    Ma Z; Zhou Z; Zhuang H; Li Z; Ma Z; Huang B; Liu C; Gong Y; Zou Y; Zheng Z; Huang S; Zhang C; Hou B
    Dis Markers; 2021; 2021():6682697. PubMed ID: 33747255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways.
    Hu H; Wang F; Wang M; Liu Y; Wu H; Chen X; Lin Q
    Int J Med Sci; 2020; 17(6):807-814. PubMed ID: 32218702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-lymphoid tyrosine kinase-mediated FAM83A phosphorylation elevates pancreatic tumorigenesis through interacting with β-catenin.
    Zhou C; Zhu X; Liu N; Dong X; Zhang X; Huang H; Tang Y; Liu S; Hu M; Wang M; Deng X; Li S; Zhang R; Huang Y; Lyu H; Xiao S; Luo S; Ali DW; Michalak M; Chen XZ; Wang Z; Tang J
    Signal Transduct Target Ther; 2023 Feb; 8(1):66. PubMed ID: 36797256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas.
    Parameswaran N; Bartel CA; Hernandez-Sanchez W; Miskimen KL; Smigiel JM; Khalil AM; Jackson MW
    Sci Rep; 2019 Sep; 9(1):13396. PubMed ID: 31527715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer.
    Jin Y; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Jun; 20(1):172. PubMed ID: 35650627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
    Xiao G; Wang P; Zheng X; Liu D; Sun X
    Cell Cycle; 2019 Nov; 18(21):2972-2985. PubMed ID: 31522616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
    Zhang J; Sun G; Mei X
    Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. nc-RNA-mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer.
    Zhao YX; Xu BW; Wang FQ; Jiang FY; Xu JW; Yu DX
    Cancer Med; 2023 Feb; 12(4):5110-5123. PubMed ID: 36457244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway.
    Rong L; Li H; Li Z; Ouyang J; Ma Y; Song F; Chen Y
    Front Med (Lausanne); 2020; 7():608441. PubMed ID: 33344485
    [No Abstract]   [Full Text] [Related]  

  • 13. CircMIIP Contributes to Non-Small Cell Lung Cancer Progression by Binding miR-766-5p to Upregulate FAM83A Expression.
    Wang T; Zhu X; Wang K
    Lung; 2022 Feb; 200(1):107-117. PubMed ID: 35013754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of MAD2L1 mediated by ncRNA axis is associated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma: A review.
    Liu S; Miao M; Kang L
    Medicine (Baltimore); 2023 Jan; 102(2):e32625. PubMed ID: 36637946
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yu J; Hou M; Pei T
    DNA Cell Biol; 2020 May; 39(5):890-899. PubMed ID: 32282228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F; Li C; Zhang X; Peng W; Wen T
    Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM83A has a pro-tumor function in ovarian cancer by affecting the Akt/Wnt/β-catenin pathway.
    Zhao J; Zhao F; Yang T; Tian S; Zhao M; Wang S; Yang X
    Environ Toxicol; 2022 Apr; 37(4):695-707. PubMed ID: 34931434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA FEZF1-AS1 promotes rectal cancer progression by competitively binding miR-632 with FAM83A.
    Xie R; Liu C; Liu L; Lu X; Tang G
    Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):452-462. PubMed ID: 35607960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of MicroRNA-1-FAM83A Axis Dysfunction in the Growth and Motility of Lung Cancer Cells.
    Liu PJ; Chen YH; Tsai KW; Yeah HY; Yeh CY; Tu YT; Yang CY
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway.
    Li X; Deng SJ; Zhu S; Jin Y; Cui SP; Chen JY; Xiang C; Li QY; He C; Zhao SF; Chen HY; Niu Y; Liu Y; Deng SC; Wang CY; Zhao G
    Oncotarget; 2016 Feb; 7(5):6000-14. PubMed ID: 26755660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.